--- a
+++ b/clusters/9knumclustersv2/clust_1146.txt
@@ -0,0 +1,47 @@
+No patients that are known to be pregnant or nursing
+Patients who are pregnant or actively nursing an infant are not eligible
+Patients who are pregnant or nursing
+Patients who are pregnant or nursing.
+Patients must not be pregnant or nursing
+Subjects must not be pregnant or nursing due to the potential for congenital abnormalities and the potential of this regimen to harm nursing infants.
+Subjects must not be pregnant or nursing due to the potential for congenital abnormalities and the potential of this regimen to harm nursing infants
+Non-pregnant and non-nursing; pregnant and nursing patients may not be enrolled; women and men of reproductive potential must agree to use acceptable forms of contraception during the study
+Patients who are pregnant or nursing
+Patients who are pregnant or nursing
+Pregnant or nursing patients
+PHASE I: Patients must not be pregnant or nursing as the potential of this regimen to harm nursing infants has not been evaluated
+PHASE II: Patients must not be pregnant or nursing as the potential of this regimen to harm nursing infants has not been evaluated
+Subjects must not be pregnant or nursing due to the potential for congenital abnormalities and the potential of this regimen to harm nursing infants.
+Patients who are pregnant or nursing
+Patients who are pregnant or nursing
+Pregnant or nursing patients
+Patients who are pregnant or nursing
+Patients who are pregnant or nursing
+Patient must not be pregnant because of the risk of harm to the fetus; nursing women may participate only if nursing is discontinued, due to the possibility of harm to nursing infants from the treatment regimen; women/men of reproductive potential must agree to use an effective contraception method
+Patients must not be pregnant or nursing due to the potential for congenital abnormalities and the potential of this regimen to harm nursing infants
+Patients must not be nursing due to the potential for congenital abnormalities and the potential of this regimen to harm nursing infants
+Patients must not be pregnant or nursing
+Patients must not be pregnant or nursing
+Patients who are pregnant or nursing
+Patients of childbearing potential, not practicing adequate contraception, patients who are pregnant or patients who are nursing are not eligible for this trial; bevacizumab should not be administered to nursing women
+Patients who are pregnant or nursing
+Patients must be non-pregnant and non-nursing
+Patients who are pregnant or nursing
+Patients who are pregnant or nursing
+Patients who are pregnant or nursing
+Patients who are pregnant or nursing are not eligible
+Patients pregnant or nursing
+Non-pregnant and non-nursing; pregnant or nursing patients may not be enrolled; women and men of reproductive potential should agree to use an effective means of birth control
+Patients who are pregnant or nursing
+Patients who are pregnant or nursing.
+Patients who are pregnant, nursing, or who wish to become pregnant during the study
+Patients who are pregnant or nursing
+Patients must not be pregnant or nursing
+Patients must not be pregnant or nursing
+Patients who are pregnant or nursing
+Patients who are pregnant or nursing are ineligible
+No exclusion criteria for pregnant or nursing patients from participating in this study (of note, pregnant patients will not be treated with vaginal brachytherapy, a requirement for enrolling on this study)
+Pregnant or nursing patients will not be included in the study
+Patients who are pregnant or nursing
+Pregnancy or nursing patients
+Known pregnant or nursing patients